Top compounds associated with response to PILRB


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA azacitidine CTRPv2 pan-cancer AAC 0.12 0.001
mRNA canertinib CTRPv2 pan-cancer AAC 0.12 0.002
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA bendamustine CTRPv2 pan-cancer AAC 0.11 0.004
mRNA neratinib CTRPv2 pan-cancer AAC 0.1 0.005
mRNA austocystin d CTRPv2 pan-cancer AAC 0.1 0.007
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.094 0.007
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.1 0.008
Download CSV